FDA Drug Application (077916) for EFAVIRENZ by CIPLA LIMITED

Back to FDA Applications sponsored by CIPLA LIMITED

Application Number077916
Product Number001
FormTABLET; ORAL
Dosage600MG
Product Market Status Tentative Approval
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameEFAVIRENZ
Active IngredientEFAVIRENZ

Active IngredientCount
List of drugs with Active Ingredient EFAVIRENZ11


Back to FDA Applications sponsored by CIPLA LIMITED